Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed2
Recruiting4
Terminated1

Role Distribution

Principal Investigator5
Other Roles2
PI Rate71%

Activity Timeline

Clinical Trials (7)

NCT07178340Phase 2Recruiting
Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach
Hepatoid Adenocarcinoma of Stomach
PrincipalinvestigatorStart date: 2025-09-18
NCT06992362Phase 2Recruiting
Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach
Hepatoid Adenocarcinoma of Stomach
PrincipalinvestigatorStart date: 2025-05-20
NCT07547787Recruiting
A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)
Locally Advanced Unresectable or Metastatic Gastric Cancer
PrincipalinvestigatorStart date: 2024-12-26
NCT05008783Phase 3Completed
A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
PrincipalinvestigatorStart date: 2021-09-17
NCT04047953Not ApplicableRecruiting
Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma
Gastric Adenocarcinoma
PrincipalinvestigatorStart date: 2019-09-10

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lin Shen, MD

Peking University Cancer Hospital & Institute

Moderately Similar
20 trials

Shared therapeutic areas:

Cancer of StomachGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more

Worked with same sponsors:

AkesoPeking University Cancer Hospital & Institute
Collaborated on 2 trials
Similarity Score48%

Yelena Janjigian, MD

Memorial Sloan Kettering Cancer Center

Related
12 trials

Shared therapeutic areas:

Cancer of StomachGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Similarity Score18%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Cancer of StomachGastric Adenocarcinoma
Similarity Score12%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score6%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score6%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score6%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score6%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score6%

Gregory Reid, MSc, MBA

MethylGene Inc.

Related
13 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score6%

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Related
13 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT07178340Phase 2PrincipalInvestigator

Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach

Hepatoid Adenocarcinoma of Stomach
Recruiting
NCT06992362Phase 2PrincipalInvestigator

Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach

Hepatoid Adenocarcinoma of Stomach
Recruiting
NCT07547787PrincipalInvestigator

A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)

Locally Advanced Unresectable or Metastatic Gastric Cancer
Recruiting
NCT05008783Phase 3PrincipalInvestigator

A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma

Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Completed
NCT04047953Not ApplicablePrincipalInvestigator

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

Gastric Adenocarcinoma
Recruiting
NCT03425058StudyChair

Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

Gastric Cancer
Completed
NCT02867839Phase 3StudyChair

Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer

Gastric Cancer
Terminated

All 7 trials loaded